Signal transduction in neuropathic pain, with special emphasis on the analgesic role of opioids - Part I: The basic science of phenotype expression in normal and regenerating nerves

Pain Reviews

Volumn 6, Issue 1, 1999, Pages 3-33

  McCormack, Keith ^a,b  

^a Drug Research Group   (United Kingdom)

^b McCormack Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CALCIUM; CALMODULIN; GROWTH FACTOR; NICOTINIC RECEPTOR; OPIATE; OPIATE RECEPTOR; PHOSPHATIDYLCHOLINE; PROTEIN P21;

CALCIUM CURRENT; CELL SURVIVAL; CYTOPLASM; GENE EXPRESSION; HUMAN; HYPOTHESIS; NERVE REGENERATION; PAIN; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032929432     PISSN: 09681302     EISSN: None     Source Type: Journal    
DOI: 10.1191/096813099676046619     Document Type: Review

References (275)

1. Brune K, McCormack K. The over-the-counter use of nonsteroidal anti-inflammatory drugs (NSAIDs) and other antipyretic analgesics. In: Lewis AJ, Furst D eds. Nonsteroidal anti-inflammatory drugs: mechanisms and clinical use, second edition. New York: Marcel Dekker, 1994: 97-126.
2. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 1990; 43: 273-86.
3. Benedetti F, Vighetti S, Amanzio M et al. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain 1998; 74: 205-11.
4. Lasagna L, Beecher HK. The optimal dose of morphine. JAMA 1954; 156: 230-34.
5. Genova-Strickland DI. Living with chronic pain [letter]. Clin J Pain 1997; 13: 178-79.
6. de Groot JF, Coggeshall RE, Carlton SM. The reorganization of μ opioid receptors in the rat dorsal horn following peripheral axotomy. Neurosci Lett 1997; 233: 113-16.
7. Hama AT, Unnerstall JR, Siegan JB, Sagen J. Modulation of NMDA receptor expression in the rat spinal cord by peripheral nerve injury and adrenal medullary grafting. Brain Res 1995; 687: 103-13.
8. Price DD, Bennett GJ, Rafii A. Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain 1989; 36: 273-88.
9. 1 subunit is responsible for channel inhibition by G protein-coupled receptors. Proc Natl Acad Sci U S A 1997; 94: 8866-71.
10. Ikeda SR. Voltage-dependent modulation of N-type calcium channels by G protein βγ subunits. Nature 1996; 380: 255-58.
11. De Waard M, Liu H, Walker D, Scott VE, Gurnett CA, Campbell KP. Direct binding of G-protein βγ complex to voltage-dependent calcium channels. Nature 1997; 385: 446-50.
12. 2+ channels by G protein βγ subunits. Nature 1996; 380: 258-62.
13. Rusin KI, Moises HC. μ-opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons. J Neurosci 1995; 15: 4315-27.
14. Bourinet E, Soong TW, Stea A, Snutch TP. Determinants of the G protein-dependent opioid modulation of neuronal calcium channels. Proc Natl Acad Sci U S A 1996; 93: 1486-91.
15. Bean BP. Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature 1989; 340: 153-56.
16. Dunlap K, Fischbach GD. Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurons. J Physiol (Lond) 1981; 317: 519-35.
17. 2+ currents by a μ-opioid in a defined subset of rat sensory neurons. J Neurosci 1993; 13: 867-73.
18. 2+ currents in neuronal F-11 cell. Brain Res 1997; 766: 66-71.
19. Moises HC, Rusin KI, Macdonald RL. μ-opioid receptor-mediated reduction of neuronal calcium current occurs via a Go-type GTP binding protein. J Neurosci 1994; 14: 3842-51.
20. 2+ current in magnocellular neurons of the rat basal forebrain. Brain Res 1997; 758: 118-26.
21. 5)-enkephalin administered intracerebroventricularly in the mouse. J Pharmacol Exp Ther 1997; 282: 961-66.
22. Wiley JW, Moises HC, Gross RA, MacDonald RL. Dynorphin A-mediated reduction in multiple calcium currents involves a Goα subtype G protein in rat primary afferent neurons. J Neurophysiol 1997; 77: 1338-18.
23. Formenti A, Arrigoni E, Martina M, Taverna S, Avanzini G, Mancia M. Calcium influx in rat thalamic relay neurons through voltage-dependent calcium channels is inhibited by enkephalin. Neurosci Lett 1995; 201: 21-24.
24. 2+ channels in the rat periaqueductal gray neurons by μ-type opioid agonist. J Neurophysiol 1997; 77: 1418-24.
25. Hall KE, Sima AA, Wiley JW. Opiate-mediated inhibition of calcium signalling is decreased in dorsal root ganglion neurons from the diabetic BB/W rat. J Clin Invest 1996; 97: 1165-72.
26. 2+ channels in rat dorsal root ganglion neurons. J Neurophysiol 1995; 73: 1793-98.
27. 2+ channels. J Neurosci 1995; 15: 4124-32.
28. Collin E, Mauborgne A, Bourgoin S, Chantrel D, Hamon M, Cesselin F. In vivo tonic inhibition of spinal substance P (-like material) release by endogenous opioid(s) acting at δ receptors. Neuroscience 1991; 44: 725-31.
29. Go VL, Yaksh TL. Release of substance P from the cat spinal cord. J Physiol (Lond) 1987; 391: 141-67.
30. Pohl L, Lombard MC, Bourgoin S et al. Opioid control of the in vitro release of calcitonin gene-related peptide from primary afferent fibres projecting in the rat cervical cord. Neuropeptides 1989; 14: 151-59.
31. Ueda M, Sugimoto K, Oyama T, Kuraishi Y, Satoh M. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices. Neuropharmacology 1995; 34: 303-308.
32. 2-, and μ-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J Neurosci 1994; 14: 4965-71.
33. Grudt T, Williams JT. μ-opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat. J Neurosci 1994; 14: 1646-54.
34. Hammond DL, Wang H, Nakashima N, Basbaum AI. Differential effects of intrathecally administered δ and μ opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. J Pharmacol Exp Ther 1998; 284: 378-87.
35. 1 subunit. Nature 1997; 385: 442-46.
36. Luebke JI, Dunlap K. Sensory neuron N-type calcium currents are inhibited by both voltage-dependent and -independent mechanisms. Pflügers Arch 1994; 428: 499-507.
37. 2+ current of rat dorsal raphe neurons. Neurosci Lett 1997; 224: 87-90.
38. Toth PT, Shekter LR, Ma GH, Philipson LH, Miller RJ. Selective G-protein regulation of neuronal calcium channels. J Neurosci 1996; 16: 4617-24.
39. 2+ current in excitable cells. Trends Neurosci 1996; 19: 35-43.
40. Dolphin AC. Mechanisms of modulation of voltage-dependent calcium channels by G proteins. J Physiol (Lond) 1998; 506: 3-11.
41. Wang J, Ren M, Han J. Mobilization of calcium from intracellular stores as one of the mechanisms underlying the antiopioid effect of cholecystokinin octapeptide. Peptides 1992; 13: 947-51.
42. Schafer M, Zhou L, Stein C. Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue. Neuroscience 1998; 82: 603-11.
43. B) receptors to phospholipase C and protein kinase C in AR4-2J tumoral cells. Regul Pept 1994; 52: 31-38.
44. Willems PH, Smeets RL, Bosch RR, Garner KM, Van Mackelenbergh MG, De Pont JJ. Protein kinase C activation inhibits receptor-evoked inositol trisphosphate formation and induction of cytosolic calcium oscillations by decreasing the affinity-state of the cholecystokinin receptor in pancreatic acinar cells. Cell Calcium 1995; 18: 471-83.
45. Zhang X, Dagerlind A, Elde RP et al. Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy. Neuroscience 1993; 57: 227-33.
46. Xu XJ, Puke MJ, Verge VM, Wiesenfeld-Hallin Z, Hughes J, Hökfelt T. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci Lett 1993; 152: 129-32.
47. Saika T, Kiyama H, Matsunaga T, Tohyama M. Differential regulation of phospholipase C isozymes in the rat facial nucleus following axotomy. Neuroscience 1994; 59: 121-29.
48. Taylor GD, Fee JA, Silbert DF, Hofmann SL. PI-specific phospholipase C 'α' from sheep seminal vesicles is a proteolytic fragment of PI-PLCδ. Biochem Biophys Res Commun 1992; 188: 1176-83.
49. Thomas G, Chung M, Cohen CJ. A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent. Circ Res 1985; 56: 87-96.
50. 2+ channel ligands. J Physiol (Lond) 1991; 432: 23-43.
51. Zhu Y, Yakel JL. Calcineurin modulates G protein-mediated inhibition of N-type calcium channels in rat sympathetic neurons. J Neurophysiol 1997; 78: 1161-65.
52. Lyons WE, Steiner JP, Synder SH, Dawson TM. Neuronal regeneration enhances the expression of the immunophilin FKBP-12. J Neurosci 1995; 15: 12985-94.
53. Ekström PA, Bergstrand H, Edström A. Effects of protein kinase inhibitors on regeneration in vitro of adult frog sciatic sensory axons. J Neurosci Res 1992; 31: 462-69.
54. Wiklund P, Ekström PA, Edbladh M, Tonge D, Edström A. Protein kinase C and mouse sciatic nerve regeneration. Brain Res 1996; 715: 145-54.
55. Heacock AM, Agranoff BW. Protein kinase inhibitors block neurite outgrowth from explants of goldfish retina. Neurochem Res 1997; 22: 1179-85.
56. Roberts RE, McLean WG. Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res 1997; 754: 147-56.
57. Gandhi VJ, Jones DJ. Protein kinase C modulates the release of (3H)5-hydroxytryptamine in the spinal cord of the rat: the role of L-type voltage-dependent calcium channels. Neuropharmacology 1992; 31: 1101-109.
58. Coghlan VM, Perrino BA, Howard M et al. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 1995; 267: 108-11.
59. Steiner JP, Dawson TM, Fotuhi M, Synder SH. Immunophilin regulation of neurotransmitter release. Mol Med 1996; 2: 325-33.
60. Nah SY, Saya D, Barg J, Vogel Z. Opiate receptor agonists regulate phosphorylation of synapsin I in cocultures of rat spinal cord and dorsal root ganglion. Proc Natl Acad Sci USA 1993; 90: 4052-56.
61. Matus-Leibovitch N, Ezra Macabee V, Saya D et al. Increased expression of synapsin I mRNA in defined areas of the rat central nervous system following chronic morphine treatment. Brain Res Mol Brain Res 1995; 34: 221-30.
62. Williams S, Serafin M, Muhlethaler M, Bernheim L. Facilitation of the N-type calcium current is dependent on the frequency of action potential-like depolarizations in dissociated cholinergic basal forebrain neurons of the guinea pig. J Neurosci 1997; 17: 1625-32.
63. Wall PD, Devor M, Inbal R et al. Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa. Pain 1979; 7: 103-11.
64. Xiao WH, Bennett GJ. Synthetic ω-conopeptides applied to the site of nerve injury suppress neuropathic pain in rats. J Pharmacol Exp Ther 1995; 274: 666-72.
65. Chaplan SR, Pogrel J, Yaksh TL. Pharmacologic modulation of tactile allodynia in a rat neuropathy model [Abstract]. In: Gebhart GF, Hammond DL, Jensen TS eds. Proceedings of the 7th World Congress on Pain (Progress in pain research and management, vol. 2); 1993 Aug 22-27; Paris. Seattle: IASP Press, 1994: 37 (Abstr 98).
66. Wang Y-X, Bowersox SS, Luther RR. SNX-111, a selective N-type calcium channel antagonist, blocks mechanical allodynia in a rat model of experimental allergic neuritis [Abstract]. In: Jensen TS, Turner JA, Wiesenfeld-Hallin Z eds. Proceedings of the 8th World Congress on Pain (Progress in pain research and management, vol. 8); 1996 Aug 17-22; Vancouver, Canada. Seattle: IASP Press, 1997: 357 (Abstr 94).
67. Gutlove DP, Brose WG, Luther RR, Bowersox SS. Use of intrathecal SNX-111, a novel analgesic, in the management of intractable brachial plexus avulsion pain [Abstract]. In: Jensen TS, Turner JA, Wiesenfeld-Hallin Z eds. Proceedings of the 8th World Congress on Pain (Progress in pain research and management, vol. 8); 1996 Aug 17-22; Vancouver, Canada. Seattle: IASP Press, 1997: 358 (Abstr 95).
68. Chaplan SR, Pogrel JW, Yaksh TL. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 1994; 269: 1117-23.
69. Sattler R, Tymianski M, Feyaz I, Hafner M, Tator CH. Voltage-sensitive calcium channels mediated calcium entry into cultured mammalian sympathetic neurons following neurite transection. Brain Res 1996; 719: 239-46.
70. 2+ concentration in the spinal dorsal horn in an animal model of neuropathic pain. Pain 1996; 68: 85-96.
71. Vigers AJ, Pfenniger KH. N-type and L-type calcium channels are present in nerve growth cones: numbers increase on synaptogenesis. Brain Res Dev Brain Res 1991; 60: 197-203.
72. Gispen WH, Hamers FP. Calcium and neuronal dysfunction in peripheral nervous system. Ann N Y Acad Sci 1994; 747: 419-30.
73. McGuire D, Bowersox S, Fellmann JD, Luther RR. Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans. J Cardiovasc Pharmacol 1997; 30: 400-403.
74. 2+ channels are present in secretory granules and are transiently translocated to the plasma membrane during regulated exocytosis. J Biol Chem 1996; 271: 30096-104.
75. Passafaro M, Clementi F, Sher E. Metabolism of ω-conotoxin-sensitive voltage-operated calcium channels in human neuroblastoma cells: modulation by cell differentiation and anti-channel antibodies. J Neurosci 1992; 12: 3372-79.
76. 2+ channels. Neuron 1994; 12: 317-26.
77. 2+ currents induced by daily stimulation of hippocampal neurons with glutamate. J Neurosci 1994; 14: 545-53.
78. Billah MM, Anthes JC. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J 1990; 269: 281-91.
79. Taki T, Kanfer N. Partial purification and properties of a rat brain phospholipase. J Biol Chem 1979; 254: 9761-65.
80. Hattori H, Kanfer JN. Synaptosomal phospholipase D potential role in providing choline for acetylcholine synthesis. J Neurochem 1985; 45: 1578-84.
81. Qian Z, Drewes LR. Muscarinic acetylcholine receptor regulates phosphatidylcholine phospholipase D in canine brain. J Biol Chem 1989; 274: 21720-24.
82. Gustavsson L, Alling C. Formation of phosphatidylethanol in rat brain by phospholipase D. Biochem Biophys Res Commun 1987; 142: 958-63.
83. Martinson EA, Trilivas I, Brown JH. Rapid protein kinase C-dependent activation of phospholipase D leads to delayed 1,2-diglyceride accumulation. J Biol Chem 1990; 265: 22282-87.
84. Sandmann J, Wurtman RJ. Stimulation of phospholipase D activity in human neuroblastoma (LA-N-2) cells by activation of muscarinic acetylcholine receptors or by phorbol esters: relationship to phosphoinositide turnover. J Neurochem 1991; 56: 1312-19.
85. Chattopadhyay J, Natarajan V, Schmidd HH. Membrane-associated phospholipase D activity in rat sciatic nerve. J Neurochem 1991; 57: 1429-36.
86. Eggen BJ, Eichberg J. Phorbol ester-mediated stimulation of phospholipase D activity in sciatic nerve from normal and diabetic rats. J Neurochem 1992; 59: 1467-73.
87. Gilad GM, Gilad VH. Increased choline kinase activity in the rat superior cervical ganglion after axonal injury. Brain Res 1981; 220: 420-26.
88. Natarajan V, Yao YK, Dyck PJ, Schmidd HH. Early stimulation of phosphatidylcholine biosynthesis during wallerian degeneration of rat sciatic nerve. J Neurochem 1982; 38: 1419-28.
89. Alberghina M, Viola M, Giuffrida AM. Rapid axonal transport of glycerophospholipids in regenerating hypoglossal nerve of the rabbit. J Neurochem 1983; 40: 25-31.
90. Alberghina M, Moschella F, Viola M, Brancati V, Micali G, Giuffrida M. Changes in rapid transport of phospholipids in the rat sciatic nerve during axonal regeneration. J Neurochem 1983; 40: 32-39.
91. Hofteig JH, Vo PN, Yates AJ, Leon KS. Peripheral nerve phospholipid composition: development in normal nerve and age-dependent changes in wallerian degenerated nerve. J Neurochem 1982; 39: 401-408.
92. Geny B, Cockcroft S. Synergistic activation of phospholipase D by protein kinase C- and G-protein-mediated pathways in streptolysin O-permeabilized HL60 cells. Biochem J 1992; 284: 531-38.
93. Pyne S, Pyne NJ. Phospholipase D regulation involves extracellular calcium as a conditional requirement for subsequent stimulation by protein kinase C. Biochem Soc Trans 1995; 23: 199S.
94. Mangoura D, Dawson G. Opioid peptides activate phospholipase D and protein kinase C-epsilon in chick embryo neuron cultures. Proc Natl Acad Sci U S A 1993; 90: 2915-19.
95. Banerjee P, Chromy BA, Berry Kravis E, Hammond D, Singh JK, Dawson G. Stable expression and heterologous coupling of the kappa opioid receptor in cell lines of neural and nonneural origin. Life Sci 1996; 58: 1277-84.
96. Mangoura D. μ-opioids activate tyrosine kinase focal adhesion kinase and regulate cortical cytoskeleton proteins cortactin and vinculin in chick embryonic neurons. J Neurosci Res 1997; 50: 391-401.
97. Zheng L, Krsmanovic LZ, Vergara LA, Catt KJ, Stojilkovic SS. Dependence of intracellular signaling and neurosecretion on phospholipase D activation in immortalized gonadotropin-releasing hormone neurons. Proc Natl Acad Sci U S A 1997; 94: 1573-78.
98. Decker ER, Dani JA. Calcium permeability of the nicotinic acetylcholine receptor: the single-channel calcium influx is significant. J Neurosci 1990; 10: 3413-20.
99. Vernino S, Amador M, Luetje CW, Patrick J, Dani JA. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron 1992; 8: 127-34.
100. Vernino S, Rogers M, Radcliffe KA, Dani JA. Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors. J Neurosci 1994; 14: 5514-24.
101. Mulle C, Vidai C, Benoit P, Changeux JP. Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system. J Neurosci 1991; 11: 2588-97.
102. Mulle C, Choquet D, Korn H, Changeux JP. Calcium influx through nicotinic receptor in rat central neurons: its relevance to cellular regulation. Neuron 1992; 8: 135-43.
103. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 1995; 269: 1692-96.
104. Alkondon M, Pereira EF, Albuquerque EX. Mapping the location of functional and γ-aminobutyric acid A receptors on hippocampal neurons. J Pharmacol Exp Ther 1996; 279: 1491-506.
105. Gray R, Rajan SS, Radcliffe KA, Yakehiro M, Dani JA. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 1996; 383: 713-16.
106. Harkins AB, Fox AP. Activation of nicotinic acetylcholine receptors augments calcium channel-mediated exocytosis in rat pheochromocytoma (PC12) cells. J Gen Physiol 1998; 111: 257-69.
107. Langer SZ. 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol Sci 1997; 18: 95-99.
108. Roberts RG, Stevenson JE, Westerman RA, Pennefather J. Nicotinic acetylcholine receptors on capsaicin-sensitive nerves. NeuroReport 1995; 6: 1578-82.
109. Shi J, Zhou J, Ouyang X, Zhong J, Guan X. Influences of capsaicin and electroacupuncture at 'point' on acetylcholine (ACh) release in the spinal dorsal horn of rats. Chen Tzu Yen Chiu 1995; 20: 22-27.
110. Min CK, Owens J, Weilund GA. Characterization of the binding of (3H) substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque. Mol Pharmacol 1994; 45: 221-27.
111. Gillberg PG, Askmark H. Changes in cholinergic and opioid receptors in the rat spinal cord, dorsal root and sciatic nerve after ventral and dorsal root lesion. J Neural Transm Gen Sect 1991; 85: 31-39.
112. Besse D, Lombard MC, Zajac JM, Roques BP, Besson JM. Pre- and postsynaptic distribution of μ, δ and K opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res 1990; 521: 15-22.
113. Albuquerque EX, Pereira EF, Castro NG et al. Nicotinic receptor function in the mammalian central nervous system. Ann N Y Acad Sci 1995; 757: 48-72.
114. Albuquerque EX, Pereira EF, Alkondon M, Schrattenholz A, Maelicke A. Nicotinic acetylcholine receptors on hippocampal neurons: distribution on the neuronal surface and modulation of receptor activity. J Recept Signal Transduct Res 1997; 17: 243-66.
115. Liu H, Mantyh PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 1997; 386: 721-24.
116. Shigemoto R, Ohishi H, Nakanishi S, Mizuno N. Expression of the mRNA for the rat NMDA receptor (NMDAR1) in the sensory and autonomie ganglion neurons. Neurosci Lett 1992; 144: 229-32.
117. Liu H, Wang H, Sheng M, Jan LY, Yan YN, Basbaum AI. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci U S A 1994; 91: 8383-87.
118. Jinno S, Hua XY, Yaksh TL. Nicotine and acetylcholine induce release of calcitonin-gene-related peptide from rat trachea. J Appl Physiol 1994; 76: 1651-56.
119. Wonnacott S, Irons J, Lunt GG, Rapier CM, Albuquerque EX. αBungarotoxin and presynaptic nicotinic receptors: functional studies. In: Clementi F, Gotti C, Sher E eds. Nicotinic acetylcholine receptors in the nervous system. Berlin: Springer-Verlag, 1988: 41-60.
120. Wonnacott S, Drasdo A, Sanderson E, Rowell P. Presynaptic nicotinic receptors and the modulation of transmitter release. In: The biology of nicotine dependence (Ciba Foundation Symposium, vol. 152). Chichester: Wiley, 1990: 87-105.
121. Lena C, Changeux JP, Mulle C. Evidence for 'preterminal' nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J Neurosci 1993; 13: 2680-88.
122. 2+ in cultured cortical neurons. Neuron 1993; 11: 751-57.
123. Khan IM, Marsala M, Printz MP, Taylor P, Yaksh TL. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats. J Pharmacol Exp Ther 1996; 278: 97-106.
124. Puttfarcken PS, Manelli AM, Arneric SP, Donnelly Roberts DL. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells. J Neurochem 1997; 69: 930-38.
125. Francel PC, Harris K, Smith M, Fishman MC, Dawson G, Miller RJ. Neurochemical characteristics of a novel dorsal root ganglion X neuroblastoma hybrid cell line, F-11. J Neurochem 1987; 48: 1624-31.
126. Platika D, Boulos MH, Baizer L, Fishman MC. Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells. Proc Natl Acad Sci U S A 1985; 82: 3499-503.
127. Zarrindast MR, Pazouki M, Nassiri Rad S. Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception. Pharmacol Toxicol 1997; 81: 209-13.
128. Damaj MJ, Fei Yin M, Dukat M, Glassco W, Glennon RA, Martin BR. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J Pharmacol Exp Ther 1998; 284: 1058-65.
129. Bannon AW, Decker MW, Holladay MW et al. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 1998; 279: 77-81.
130. Decker MW, Bannon AW, Buckley MJ et al. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. Eur J Pharmacol 1998; 346: 23-33.
131. Duggan AW, Weihe E. Central transmission of impulses in nociceptors: events in the superficial dorsal horn. In: Basbaum AI, Besson J-M eds. Towards a new pharmacotherapy of pain. Chester: Wiley, 1991: 35-67.
132. LoPachin RM, Lehning EJ. Mechanism of calcium entry during axon injury and degeneration. Toxicol Appl Pharmacol 1997; 143: 233-44.
133. 2-adrenergic, and muscarinic cholinergic receptors in NCB-20 cells. J Neurochem 1988; 50: 17-26.
134. 2+ is associated with irreversible tissue injury after brain trauma. J Biol Chem 1988; 263: 757-61.
135. McIntosh TK, Smith DH, Meaney DF, Kotapka MJ, Generelli TA, Graham DI. Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab Invest 1996; 74: 315-42.
136. Vink R. Nuclear magnetic resonance characterization of secondary mechanisms following traumatic brain injury. Mol Chem Neuropathol 1993; 18: 279-97.
137. Heath DL, Vink R. Brain intracellular free magnesium declines after impact-acceleration-induced brain injury in rats. Neurosci Res Commun 1996; 18: 163-68.
138. Vink R, Faden AI, McIntosh TK. Changes in cellular bioenergetic state following graded traumatic brain injury in rats: determination by phosphorus 31 magnetic resonance spectroscopy. J Neurotrauma 1988; 5: 315-30.
139. Golding EM, Vink R. Efficacy of competitive vs noncompetitive blockade of the NMDA channel following traumatic brain injury. Mol Chem Neuropathol 1995; 24: 137-50.
140. McIntosh TK, Vink R, Soares H, Hayes R, Simon R. Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J Neurochem 1990; 55: 1170-79.
141. Ikeuchi Y, Nishizaki T, Matsuoka T, Sumikawa K. Long-lasting enhancement of ACh receptor currents by lysophospholipids. Brain Res Mol Brain Res 1997; 45: 317-20.
142. Tence M, Murphy N, Cordier J, Premont J, Glowinski J. Synergistic effects of acetylcholine and glutamate on the release of arachidonic acid from cultured striatal neurons. J Neurochem 1995; 64: 1605-13.
143. Stella N, Pellerin L, Magistretti PJ. Modulation of the glutamate-evoked release of arachidonic acid from mouse cortical neurons: involvement of a pH-sensitive membrane phospholipase A2. J Neurosci 1995; 15: 3307-17.
144. Nishizaki T, Sumikawa K. Lysophosphatidic acid potentiates ACh receptor currents by G-protein-mediated activation of protein kinase C. Brain Res Mol Brain Res 1997; 50: 121-26.
145. van Hoecke ML, Allen CS, Parsons SJ. Phosphotyrosine phosphatase activity associated with c-Src in large multimeric complexes isolated from adrenal medullary chromaffin cells. Biochem J 1997; 326: 271-77.
146. Mei L, Huganir RL. Purification and characterization of a protein tyrosine phosphatase which dephosphorylates the nicotinic acetylcholine receptor. J Biol Chem 1991; 266: 16063-72.
147. Swope SL, Huganir RL. Molecular cloning of two abundant protein tyrosine kinases in Torpedo electric organ that associate with the acetylcholine receptor. J Biol Chem 1993; 268: 25152-61.
148. Swope SL, Huganir RL. Binding of the nicotinic acetylcholine receptor to SH2 domains of Fyn and Fyk protein tyrosine kinases. J Biol Chem 1994; 269: 29817-24.
149. Huganir RL, Miles K, Greengard P. Phosphorylation of the nicotinic acetylcholine receptor by an endogenous tyrosine-specific protein kinase. Proc Natl Acad Sci U S A 1984; 81: 6968-72.
150. Hopfield JF, Tank DW, Greengard P, Huganir RL. Functional modulation of the nicotinic acetylcholine receptor by tyrosine phosphorylation. Nature 1988; 336: 677-80.
151. Haselbeck RC, Berg DK. Tyrosine kinase inhibitors alter composition of nicotinic receptors on neurons. J Neurobiol 1996; 31: 404-14.
152. Kohr G, De Koninck Y, Mody I. Properties of NMDA receptor channels in neurons acutely isolated from epileptic (kindled) rats. J Neurosci 1993; 13: 3612-27.
153. Xiao WH, Bennett GJ. Magnesium suppresses neuropathic pain responses in rats via a spinal site of action. Brain Res 1994; 666: 168-72.
154. Williams WR, Pugh WJ, Nicholls PJ. Receptor regulatory properties evident in the molecular similarity of nicotinic receptor ligands and adenosine triphosphate. Pharm Sci 1996; 2: 549-54.
155. Sjoberg J, Kanje M. Incorporation of (32P)phosphate into nucleotides of the dorsal root ganglia of regenerating rat sciatic nerve. Brain Res 1987; 415: 270-74.
156. Maelicke A, Coban T, Storch A, Schrattenholz A, Pereira EF, Albuquerque EX. Allosteric modulation of Torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists. J Recept Signal Transduct Res 1997; 17: 11-28.
157. Schrattenholz A, Pereira EF, Roth U, Weber KH, Albuquerque EX, Maelicke A. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol Pharmacol 1996; 49: 1-6.
158. Maelicke A, Schrattenholz A, Storch A et al. Noncompetitive agonism at nicotinic acetylcholine receptors: functional significance for CNS signal transduction. J Recept Signal Transduct Res 1995; 15: 333-53.
159. Pereira EF, Reinhardt Maelicke S, Schrattenholz A, Maelicke A, Albuquerque EX. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons. J Pharmacol Exp Ther 1993; 265: 1474-91.
160. Storch A, Schrattenholz A, Cooper JC et al. Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells. Eur J Pharmacol 1995; 290: 207-19.
161. Schroder B, Reinhardt Maelicke S, Schrattenholz A et al. Monoclonal antibodies FK1 and WF6 define two neighboring ligand binding sites on Torpedo acetylcholine receptor α-polypeptide. J Biol Chem 1994; 269: 10407-16.
162. Fels G, Plumer Wilk R, Schrieber M, Maelicke A. A monoclonal antibody interfering with binding and response of the acetylcholine receptor. J Biol Chem 1986; 261: 15746-54.
163. 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells. J Pharmacol Exp Ther 1994; 270: 768-78.
164. Chidiac P. Rethinking receptor-G protein-effector interactions. Biochem Pharmacol 1998; 55: 549-56.
165. Morris AJ, Scarlata S. Regulation of effectors by G protein α- and βγ-subunits. Recent insights from studies of the phospholipase c-beta isoenzymes. Biochem Pharmacol 1997; 54: 429-35.
166. Rebois RV, Warner DR, Basi NS. Does subunit dissociation necessarily accompany the activation of all heterotrimeric G proteins? Cell Signal 1997; 9: 141-51.
167. Gether U, Kobilka BK. G protein-coupled receptor: II. Mechanism of agonist activation. J Biol Chem 1998; 273: 17979-82.
168. Ravindra R. Is signal transduction modulated by an interaction between heterotrimeric G proteins and tubulin? Endocrine 1997; 7: 127-43.
169. Ford CE, Skiba NP, Bae H et al. Molecular basis for interactions of G protein βγ subunits with effectors. Science 1998; 280: 1271-74.
170. Dhanasekaran N, Prasad MV. G protein subunits and cell proliferation. Biol Signals Recept 1998; 7: 109-17.
171. Clapham DE, Neer EJ. G protein βγ subunits. Annu Rev Pharmacol Toxicol 1997; 37: 167-203.
172. Luttrell LM, van Biesen T, Hawes BE et al. G protein-coupled receptors and their regulation. Activation of the MAPK signalling pathway by G protein coupled receptors. Adv Second Messenger Phosphoprotein Res 1997; 31: 263-77.
173. Bohm SK, Grady EF, Bunnett NW. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J 1997; 322: 1-8.
174. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995; 80: 249-57.
175. Birnbaumer L, Abramowitz J, Brown MM. Receptor-effector coupling by G proteins. Biochim Biophys Acta 1990; 1031: 163-24.
176. Gross W, Lohse MJ. Mechanism of action of A2 adenosine receptors. II. A restricted collision-coupling model of receptor-effector interaction. Mol Pharmacol 1991; 39: 524-30.
177. Rodbell M. The role of GTP-binding proteins in signal transduction: from the sublimely simple to the conceptually complex. Curr Top Cell Regul 1992; 32: 1-17.
178. Neubig RR. Membrane organization in G-protein mechanisms. FASEB J 1994; 8: 939-46.
179. Lin HC, Duncan JA, Kozasa T, Gilman AG. Sequestration of the G protein beta gamma subunit complex inhibits receptor-mediated endocytosis. Proc Natl Acad Sci U S A 1998; 95: 5057-60.
180. Egan SE, Weinberg RA. The pathway to signal achievement [News]. Nature 1993; 365: 781-83.
181. Moodie SA, Willumsen BM, Weber MJ, Wolfman A. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 1993; 260: 1658-61.
182. Wood KW, Sarnecki C, Roberts TM, Blenis J. Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1 and RSK. Cell 1992; 68: 1041-50.
183. Faure M, Voyno Yasenetskaya T, Bourne HR. cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 1994; 269: 7851-54.
184. van Biesen T, Hawes BE, Luttrell DK et al. Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathway. Nature 1995; 376: 781-84.
185. Ito A, Satoh T, Kaziro Y, Itoh H. G protein beta gamma subunit activates Ras, Raf, and MAP kinase in HEK293 cells. FEBS Lett 1995; 368: 183-87.
186. van Biesen T, Hawes BE, Raymond RJ, Luttrell LM, Koch WJ, Lefkowitz RJ. Go-protein α-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism. J Biol Chem 1996; 271: 1266-69.
187. Dhanasekaran N, Dermott JM. Signalling by the G12 class of G proteins. Cell Signal 1996; 8: 235-45.
188. Bogoyevitch MA, Clerk A, Sugden PH. Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes. Biochem J 1995; 309: 437-43.
189. Crespo P, Xu N, Simonds WF, Gutkind JS. Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature 1994; 369: 418-20.
190. Koch WJ, Inglese J, Stone WC, Lefkowitz RJ. The binding site for the βγ subunits of heterotrimeric G proteins on the β-adrenergic receptor kinase. J Biol Chem 1993; 268: 8256-60.
191. Muller S, Lohse MJ. The role of G-protein βγ subunits in signal transduction. Biochem Soc Trans 1995; 23: 141-48.
192. Koch WJ, Hawes BE, Inglese J, Luttrell LM, Lefkowitz RJ. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates Gβγ-mediated signalling. J Biol Chem 1994; 269: 6193-97.
193. Koch WJ, Hawes BE, Allen LF, Lefkowitz RJ. Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by Gβγ activation of p21 ras. Proc Natl Acad Sci 1994; 91: 12706-10.
194. Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochim Biophys Acta 1996; 1287: 121-49.
195. Rudd CE, Janssen O, Prasad KV et al. Src-related protein tyrosine kinases and their surface receptors. Biochim Biophys Acta 1993; 1155: 239-66.
196. Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, Lefkowitz DJ. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gβγ subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 1996; 271: 19443-50.
197. Sadoshima J, Izumo S. The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 1996; 15: 775-87.
198. Touhara K, Hawes BE, van Biesen T, Lefkowitz RJ. G protein βγ subunits stimulate phosphorylation of Shc adapter protein. Proc Natl Acad Sci USA 1995; 92: 9284-87.
199. Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS, Wetzker R. Linkage of G protein-coupled receptors to the MAPK signalling pathway through PI 3-kinase γ. Science 1997; 275: 394-97.
200. Tang X, Downes CP. Purification and characterization of Gβγ-responsive phosphoinositide 3-kinases from pig platelet cytosol. J Biol Chem 1997; 272: 14193-99.
201. Sakanaka C, Ferby I, Waga I, Bito H, Shimizu T. On the mechanism of cytosolic phospholipase A2 activation in CHO cells carrying somatostatin receptor: wortmannin-sensitive pathway to activate mitogen-activated protein kinase. Biochem Biophys Res Commun 1994; 205: 18-23.
202. Rodriguez-Viciana P, Warne PH, Dhand R et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994; 370: 527-32.
203. Ferby IM, Waga I, Sakanaka C, Kume K, Shimizu T. Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils. J Biol Chem 1994; 269: 30485-88.
204. Stephens LR, Hughes KT, Irvine RF. Pathway of phosphatidylinositol (3,4,5)-trisphosphate synthesis in activated neutrophils. Nature 1991; 351: 33-39.
205. Stephens LR, Eguinoa A, Corey S, Jackson T, Hawkins PT. Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J 1993; 12: 2265-73.
206. Stephens L, Jackson T, Hawkins PT. Synthesis of phosphatidylinositol 3,4,5-trisphosphate in permeabilized neutrophils regulated by receptors and G-proteins. J Biol Chem 1993; 268: 17162-72.
207. Thelen M, Wymann MP, Langen H. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signalling in neutrophil leukocytes. Proc Natl Acad Sci U S A 1994; 91: 4960-64.
208. Traynor-Kaplan AE, Harris AL, Thompson BL, Taylor P, Sklar LA. An inositol tetrakisphosphate-continuing phospholipid in activated neutrophils. Nature 1988; 334: 353-56.
209. Chen Y, Grall D, Salcinia AE, Pelicci PG, Pouyssegur J, van Obberghen Schilling E. She adaptor proteins are key transducers of mitogenic signalling mediated by the G protein-coupled thrombin receptor. EMBO J 1996; 15: 1037-44.
210. Ptasznik A, Traynor-Kaplan A, Bokoch GM. G protein-coupled chemoattractant receptors regulate Lyn tyrosine kinase. She adapter protein signalling complexes. J Biol Chem 1995; 270: 19969-73.
211. Schieffer B, Paxton WG, Chai Q, Marrero MB, Bernstein KE. Angiotensin II controls p21ras activity via pp60c-src. J Biol Chem 1996; 271: 10329-33.
212. Wan Y, Kurosaki T, Huang XY. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature 1996; 380: 541-44.
213. Fukuda K, Kato S, Morikawa H, Shoda T, Mori K. Functional coupling of the δ-, μ-, and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem 1996; 67: 1309-16.
214. Li L-Y, Chang K-J. The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express μ-opioid receptors. Mol Pharmacol 1996; 50: 599-602.
215. Berhow MT, Hiroi N, Nestler EJ. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 1996; 16: 4707-15.
216. Ortiz J, Harris HW, Guitart Z, Terwilliger RZ, Haycock JW, Nestler EJ. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 1995; 16: 1285-97.
217. Noël F, Iourgenko V, Pouille Y, Hanoune J. Recent advances in molecular effects of opiates. Med Sci 1994; 10: 1116-26.
218. Widnell KL, Russell DS, Nestler EJ. Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci U S A 1994; 91: 10947-51.
219. Widnell KL, Self DW, Lane SB et al. Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J Pharmacol Exp Ther 1996; 276: 306-15.
220. Simpson JN, McGinty JF. Forskolin increases phosphorylated-CREB and fos immunoreactivity in rat striatum. NeuroReport 1994; 5: 1213-16.
221. Simpson JN, McGinty JF. Forskolin induces preproenkephalin and preprodynorphin mRNA in rat striatum as demonstrated by in situ hybridization histochemistry. Synapse 1995; 19: 151-59.
222. Osugi T, Ikemoto M, Tanaka H, Wang XB. Modulation by chronic morphine administration of single-stranded cAMP response element (ssCRE) binding proteins in the mouse cerebellum. Brain Res Mol Brain Res 1994; 21: 256-62.
223. Nestler EJ. Cellular responses to chronic treatment with drugs of abuse. Crit Rev Neurobiol 1993; 7: 23-39.
224. Chuang LF, Killam KF, Chuang RY. Induction and activation of mitogen-activated protein kinases of human lymphocytes as one of the signalling pathways of the immunomodulatory effects of morphine sulfate. J Biol Chem 1997; 272: 26815-17.
225. Belcheva MM, Vogel Z, Ignatova E et al. Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependence and involves Gβγ subunits. J Neurochem 1998; 70: 635-45.
226. Burt AR, Carr IC, Mullaney I, Anderson NG, Milligan G. Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse 6 opioid receptor in Rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation. Biochem J 1996; 320: 227-25.
227. Gutstein HB, Rubie EA, Mansour A, Akil H, Woodgett JR. Opioid effects on mitogen-activated protein kinase signalling cascades. Anesthesiology 1997; 87: 1118-26.
228. Lou LG, Zhang Z, Ma L, Pei G. Nociceptin/orhanin FQ activates mitogen-activated protein kinase in Chinese hamster ovary cells expressing opioid receptor-like receptor. J Neurochem 1998; 70: 1316-22.
229. Fukuda K, Shoda T, Morikawa H, Kato S, Mori K. Activation of mitogen-activated protein kinase by the nociceptin receptor expressed in Chinese hamster ovary cells. FEBS Lett 1997; 412: 290-94.
230. Yamauchi J, Nagao M, Kaziro Y, Itoh H. Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gβγ and Gαq/11 subunits. J Biol Chem 1997; 272: 27771-77.
231. Pawson T. Protein modules and signalling networks. Nature 1995; 373: 573-80.
232. Segal RA, Greenberg ME. Intracellular signalling pathways activated by neurotrophic factors. Annu Rev Neurosci 1996; 19: 463-89.
233. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180-86.
234. Minden A, Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1997; 1333: F85-F104.
235. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995; 270: 14843-16.
236. Robbins DJ, Zhen E, Owaki H et al. Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem 1993; 268: 5097-106.
237. Polakiewicz RD, Schieferl SM, Dorner LF, Kansra V, Comb MJ. A mitogen-activated protein kinase pathway is required for μ-opioid receptor desensitization. J Biol Chem 1998; 273: 12402-406.
238. 2+ current density in embryonic chick dorsal root ganglion neurons. Eur J Neurosci 1992; 4: 361-68.
239. Hescheler J, Klinz FJ, Schultz G, Wittinghofer A. Ras proteins activate calcium channels in neuronal cells. Cell Signal 1991; 3: 127-33.
240. Collin C, Papageorge AG, Lowy DR, Alkon DL. Early enhancement of calcium currents by H-ras oncoproteins injected into Hermissenda neurons. Science 1990; 250: 1743-45.
241. Fitzgerald EM, Dolphin AC. Regulation of rat neuronal voltage-dependent calcium channels by p21-ras. Eur J Neurosci 1997; 9: 1252-61.
242. Wilk-Blaszczak MA, Stein B, Xu S, Barbosa MS, Cobb MH, Belardetti F. The mitogen-activated protein kinase p38-2 is necessary for the inhibition of N-type calcium current by bradykinin. J Neurosci 1998; 18: 112-18.
243. Florian JA, Watts SW. Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine 2A receptor signal transduction. J Pharmacol Exp Ther 1998; 284: 346-55.
244. 2+ antagonists during application and after deprivation of nerve growth factor. Neurosci Lett 1993; 161: 13-16.
245. Katafuchi T, Take S, Hori T. Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J Physiol (Lond) 1993; 465: 343-57.
246. Wildering WC, Lodder JC, Kits KS, Bulloch AG. Nerve growth factor (NGF) acutely enhances high-voltage-activated calcium currents in molluscan neurons. J Neurophysiol 1995; 74: 2778-81.
247. Levine ES, Dreyfus CF, Black IB, Plummer MR. Differential effects of NGF and BDNF on voltage-gated calcium currents in embryonic basal forebrain neurons. J Neurosci 1995; 15: 3084-91.
248. Lesser SS, Lo DC. Regulation of voltage-gated ion channels in NGF and ciliary neurotrophic factor in SK-N-SH neuroblastoma cells. J Neurosci 1995; 15: 253-61.
249. Blair LA, Marshall J. IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner. Neuron 1997; 19: 421-29.
250. Wijetunge S, Hughes AD. pp60c-src increases voltage-operated calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 217: 1039-44.
251. Rusanescu G, Qi H, Thomas SM, Brugge JS, Halegoua S. Calcium influx induces neurite growth through an Src-Ras signalling cassette. Neuron 1995; 15: 1415-25.
252. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991; 14: 453-501.
253. Franklin JL, Johnson EM. Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. Trends Neurosci 1992; 15: 501-508.
254. Davies AM. The role of neurotrophins during successive stages of sensory neuron development. Prog Growth Factor Res 1994; 5: 263-89.
255. Spitzer NC, Gu X, Olsen E. Action potentials, calcium transients and the control of differentiation of excitable cells. Curr Opin Neurobiol 1994; 4: 70-77.
256. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-39.
257. Malenka RC. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 1994; 78: 535-38.
258. 2+ influx but not Trk activation. J Neurosci 1995; 15: 643-64.
259. Rosen LB, Greenberg ME. Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. Proc Natl Acad Sci U S A 1996; 93: 1113-18.
260. Rosen LB, Ginty DD, Weber MJ, Greenberg ME. Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron 1994; 12: 1207-21.
261. Shou C, Farnsworth CL, Neel BG, Feig LA. Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for Ras p21. Nature 1992; 358: 351-54.
262. Farnsworth CL, Freshney NW, Rosen LB, Ghosh A, Greenberg ME, Feig LA. Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature 1995; 376: 524-27.
263. Buchsbaum R, Telliez JB, Goonesekera S et al. The N-terminal pleckstrin, coiled-coil, and IQ domains of the exchange factor Ras-GRF act cooperatively to facilitate activation by calcium. Mol Cell Biol 1996; 16: 4888-96.
264. Fam NP, Fan WT, Wang Z, Zhang LJ, Chen H, Moran MF. Cloning and characterization of Ras-GRF2, a novel guanine nucleotide exchange factor for Ras. Mol Cell Biol 1997; 17: 1396-406.
265. Mm exchange factor by muscarinic receptors and G-protein βγ subunits. Nature 1996; 382: 268-72.
266. D'Arcangelo G, Halegoua S. A branched signaling pathway for nerve growth factor is revealed by Src-, Ras- and Raf-mediated gene inductions. Mol Cell Biol 1993; 13: 3146-55.
267. Ghosh A, Greenberg ME. Calcium signalling in neurons: molecular mechanisms and cellular consequences. Science 1995; 268: 239-47.
268. Rodriguez-Viciana P, Marte BM, Warne PH, Downward J. Phosphatidylinositol 3'-kinase: one of the effectors of Ras. Philos Trans R Soc Lond B 1996; 351: 225-32.
269. Marte BM, Rodriguez-Viciana P, Wennström S, Warne PH, Downward JH. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr Biol 1996; 7: 63-70.
270. Verkade P, Verkleij AJ, Gispen WH, Oestreicher AB. Ultrastructural evidence for the lack of co-transport of B-50/GAP-43 and calmodulin in myelinated axons of the regenerating rat sciatic nerve. J Neurocytol 1996; 25: 583-95.
271. Verkade P, Schrama LH, Verkleij AJ, Gispen WH, Oestreicher AB. Ultrastructural co-localization of calmodulin and B50/growth-associated protein-43 at the plasma membrane of proximal unmyelinated axon shafts studied in the model of the regenerating rat sciatic nerve. Neuroscience 1997; 79: 1207-18.
272. 2+-dependent binding of calmodulin to an N-terminal motif of the heterotrimeric G protein β subunit. J Biol Chem 1997; 272: 18801-807.
273. Zippel R, Gnesutta N, Matus-Leibovitch N et al. Ras-GRF, the activator of Ras, is expressed preferentially in mature neurons of the central nervous system. Mol Brain Res 1997; 48: 140-44.
274. Brambilla R, Gnesutta N, Minichiello L et al. A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature 1997; 390: 281-86.
275. Pumiglia KM, LeVine H, Haske T, Habib T, Jove R, Decker SJ. A direct interaction between G protein βγ subunits and the Raf-1 protein kinase. J Biol Chem 1995; 270: 14251-54.